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The conditioned place preference (CPP) test is frequently used to evaluate the reward-
ing properties of drugs of abuse in mice. Despite its widespread use in transgenic and
knockout experiments, there are few forward genetic studies using CPP to identify novel
genes contributing to drug reward. In this study, we tested LG/J and SM/J inbred strains
and the parents/offspring of 10 families of an F45/F46 advanced intercross line (AIL) for
methamphetamine-induced CPP (MA-CPP) once per week over 2 weeks. Both LG/J and
SM/J mice exhibited signiﬁcant MA-CPP that was not signiﬁcantly different between the
two strains. Furthermore, LG/J mice showed signiﬁcantly less acute MA-induced loco-
motor activity as well as locomotor sensitization following subsequent MA injections. AIL
mice (N = 105) segregating LG/J and SM/J alleles also demonstrated signiﬁcant MA-CPP
that was equal in magnitude between the ﬁrst and second week of training. Importantly,
MA-CPP in AIL mice did not correlate with drug-free or MA-induced locomotor activity, indi-
cating that MA-CPPwas not confounded by test session activity and implying that MA-CPP
is genetically distinct from acute psychomotor sensitivity. We estimated the heritability of
MA-CPP and locomotor phenotypes using midparent-offspring regression and maximum
likelihood estimates derived from the kinship coefﬁcients of the AIL pedigree. Heritability
estimates of MA-CPP were low (0–0.21) and variable (SE = 0–0.33) which reﬂected our
poor power to estimate heritability using only 10 midparent-offspring observations. In sum,
we established a short-term protocol for MA-CPP in AIL mice that could reveal LG/J and
SM/J alleles important for MA reward. The use of highly recombinant genetic populations
like AIL should facilitate the identiﬁcation of these genes and may have implications for
understanding psychostimulant abuse in humans.
Keywords: addiction, amphetamine, cue-associated craving, drug abuse, locomotion, pavlovian conditioning,
psychostimulants, reinforcement
INTRODUCTION
Vulnerability to psychostimulant abuse is heritable in humans and
ranges from 0.4 to 0.7 (Goldman et al., 2005; Ho et al., 2010).
Sensitivity to the subjective response to drugs of abuse is also
heritable (Nurnberger et al., 1982; Crabbe et al., 1983) and can pre-
dict drug dependence (Haertzen et al., 1983; Schuckit and Smith,
2001; Fergusson et al., 2003). It is hypothesized that genetic vari-
ants affecting the subjective rewarding properties will sometimes
be shared with those that affect drug abuse (Palmer and de Wit,
2012); indeed, there is some evidence to support this hypothesis
(Ho et al., 2010; Hart et al., 2012).
We and others previously identiﬁed quantitative trait loci
(QTL) inﬂuencing the acute locomotor response to metham-
phetamine (MA) in mice (Palmer et al., 2005; Phillips et al.,
2008; Bryant et al., 2009, 2012b; Cheng et al., 2010; Parker et al.,
2012). The locomotor stimulant and rewarding properties drugs
of abuse are in part mediated by shared neurobiological mech-
anisms involving dopamine release in the nucleus accumbens
(Di Chiara and Imperato, 1988). For this reason, locomotor
activity may be regarded as a proxy for activation of the mesolim-
bic reward circuitry whose genetic basis may provide insight
into the mechanisms governing the motivational properties of
drugs of abuse in mice and humans (Wise and Bozarth, 1987).
We previously used QTL, congenic, reverse genetic, and phar-
macological analysis of the locomotor stimulant response to
drugs of abuse in mice to identify casein kinase 1-epsilon as a
genetic regulator of sensitivity to psychostimulants and opioids
(Bryant et al., 2012b). This same gene in humans was associ-
ated with the euphoric properties of amphetamine (Veenstra-
VanderWeele et al., 2006) and the addictive properties of heroin
(Levran et al., 2008), supporting the rationale behind studying
the locomotor stimulant response to drugs of abuse. However,
the human candidate gene association studies have not yet been
replicated.
While focusing on the genetic basis of the psychomotor proper-
ties of drugs of abuse has been fruitful, an alternative approach is
to focus on a phenotype that is validated as a measure of the moti-
vational properties of drugs of abuse in both mice and humans.
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In the conditioned place preference (CPP) test, subjects express
their preference for one of two environments both before and
after this environment has been paired with drug administra-
tion. Drug-induced CPP in rodents can predict whether a drug
induces euphoria in humans (Tzschentke, 2007). Furthermore,
humans also express CPP for a drug-paired environment that is
highly correlated with the self-reported positive subjective effects
of amphetamine (Childs and deWit, 2009, 2011). This makes CPP
an especially attractive phenotype for translational genetic studies,
provided that it is a heritable trait.
We previously used a LG/J × SM/J F34 advanced intercross line
(AIL) to map QTLs inﬂuencing MA-induced locomotor activ-
ity (Cheng et al., 2010). The LG/J strain and SM/J strains were
originally selected for large and small body sizes from separate
populations and were subsequently accessioned by The Jackson
Laboratory where they were sib-sib mated to the fully inbred
state (Cheverud et al., 1996). Breeding for AIL mice began in Dr.
Jim Cheverud’s laboratory where unrelated individuals (non-sibs)
were deliberately outcrossed for several generations. We obtained
the AIL from Dr. Cheverud’s laboratory at generation F33 and
this population has now progressed to generation F50, yielding a
highly recombinant population that is ideal for ﬁnemappingQTLs
(Darvasi and Soller, 1995).
Our objectives in the present study were to determine whether
or not LG/J and SM/J parental strains showed a signiﬁcant dif-
ference in MA-induced CPP (MA-CPP; which would implicate
a genetic basis) and to evaluate MA-CPP in AIL mice with the
goal of using this population for mapping its genetic basis. We
phenotyped the LG/J and SM/J parental inbred strains and the
parents and offspring of 10 families of AIL mice. Next, we
examined the correlation of MA-CPP with the locomotor activ-
ity measures exhibited during training and testing to determine
whether this trait was distinct from MA psychomotor sensitivity
and whether it might be inﬂuenced by variation in activity levels
during preference assessment. We then calculated narrow-sense
heritability estimates of MA-CPP and the locomotor pheno-
types measured during preference assessment and CPP training.
Narrow-sense heritability represents the proportion of pheno-
typic variance explained by additive genetic variance (Visscher
et al., 2008); traits must be heritable for QTL mapping studies
to succeed.
MATERIALS AND METHODS
MICE
All experiments were performed in accordance with the National
Institutes of Health Guidelines for the Use of Laboratory Ani-
mals and were approved by the Institutional Animal Care and
Use Committee at the University of Chicago. A 12 h/12 h
light/dark cycle (lights on at 0600 hours) was used in the mouse
colony room. Behavioral testing was conducted between 0800 and
1700 hours. Mice were same-sex housed in standard shoebox
cages with corncob bedding in groups of 2–5 per cage. Thirty-
one LG/J mice (13 females, 18 males) and 31 SM/J mice (15
females, 16 males) were tested for MA-CPP. The ﬁrst of this
cohort was purchased from The Jackson Laboratory (Bar Har-
bor, ME, USA) and the second cohort was subsequently bred
in house.
LG × SM F45/F46 AIL mice were originally obtained from Jim
Cheverud’s laboratory at Washington University in St Louis at the
F33 generation and have since been bred and maintained in our
laboratory by breeding 50–70 families per generation in which
breeding pairs are chosen in a systematic manner in order to min-
imize relatedness.We used 105AILmice (55 females, 50males) for
MA-CPP. Twenty of these individuals (10 females, 10 males) were
from the F45 generation and each of these individuals was from
a different F44 family. These mice were phenotyped for MA-CPP
and then paired randomly to form 10 families (10 dams, 10 sires).
Mice were not selected based on their phenotypes. Eighty-ﬁve F46
offspring were generated from these 10 families (N = 4–11 per
family) and thus, many of these offspring were siblings. An addi-
tional 32 F44 AIL mice (N = 16 females, 16 males) from four
different F43 families were used in a saline (SAL) control exper-
iment where both sides of the CPP apparatus were paired with
SAL during training. All mice were 7–12 weeks at the beginning
of testing.
CONDITIONED PLACE PREFERENCE
We divided the open ﬁeld boxes (37.5 cm × 37.5 cm; AccuScan
Instruments, Columbus,OH,USA) into two equally sized, distinct
sides using a 30-cm tall plastic black divider with a 5 cm × 5 cm
mouse entryway excised from the bottom, middle part of the
divider. The other three walls of each side were distinguished by
visual cues (stripes on the walls) and tactile cues (ﬂoor textures;
Bryant et al., 2012a). For conﬁnement during MA and SAL trials,
we turned the divider upside down so that the entryway was not
accessible.
Mice were always administered MA (2 mg/kg i.p.) on the left
side of the apparatus (white horizontal stripes, smooth ﬂoor tex-
ture) and SAL (i.p.) on the right side (black vertical stripes, pointed
ﬂoor texture). The left side was, on average, the slightly less pre-
ferred side – there was approximately a 2–6% less initial preference
for the drug-paired side in LG/J, SM/J, and AIL mice (observed in
pilot studies and in the current study). We purposefully chose not
to use a counterbalanced design in order to avoid interactions
of drug treatment and/or genotype with a particular environ-
ment; instead, drug administration was always paired with the
left side.
A schematic of the MA-CPP protocol is shown in Figure 1; all
test sessions and training sessions lasted 30 min. On the ﬁrst day
[Day 1 (D1)], mice were assessed for initial preference for the two
sides of the apparatus. Following a SAL injection (10 ml/kg, i.p.),
mice were placed into the SAL-paired side facing the open entry-
way to the drug-paired side. The time spent on the drug-paired
side and the total distance traveled were recorded using the auto-
mated Versamax CPP and activity programs. Next, two series of
four conditioning trials were performed in which mice received
either 2 mg/kg MA (i.p.; D2, D4, D9, and D11) or SAL (i.p.; D3,
D5, D10, and D12) and were conﬁned to the MA- or SAL-paired
side; in this manner one side was always associated with MA and
the other side with SAL. After each session, mice were placed back
in their home cages. The mice were left undisturbed on D6–D7
and D13–D14. We examined MA-CPP on D8 following the ﬁrst
series of training trials and on D15 following the second series of
training trials whereby mice were administered a SAL injection
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FIGURE 1 | Schematic of the MA-CPP protocol.We used a 15-day protocol
whereby mice were assessed for initial preference for the drug-paired side
(D1, initial preference), trained for two separate 4-day sessions with
alternating injections of MA and SAL in the respective contexts (D2–D5;
D9–D12) and assessed for MA-CPP on Day 8 (D8) and Day 15 (D15). Each day
represents a 30 min session. Day, day of the protocol; Tx, treatment for that
day; SAL, saline treatment; MA, methamphetamine treatment; −, mice were
left undisturbed in their home cage in the vivarium on these days.
(10 ml/kg, i.p.), placed into the saline-paired side facing the entry-
way, and provided open access to both sides and assessed for time
spent on the drug-paired side. Thus, on D1, D8, and D15, we
obtained a measure of preference for the drug-paired side and on
D8 and D15 this increase in preference was interpreted as a con-
ditioned reward resulting from an association of the effects of the
drug with the drug-paired side.
BEHAVIORAL ANALYSIS
After establishing that sex did not interact with strain, we com-
bined sexes for all analyses. MA-CPP was analyzed using repeated
measures ANOVA (D1, D8, and D15) and/or paired t-test of the
time spent on the drug-paired side on D1, D8, and D15. The
cut-off for signiﬁcance of the comparisons between strains and
between days was Bonferroni-corrected for multiple comparisons
(0.05/number of comparisons; see Section “Results” for speciﬁc
alpha levels). Locomotor activity in the LG/J and SM/J parental
strains was analyzed using repeated measures ANOVA separately
for the MA training days (D2, D4, D9, and D11) and SAL train-
ing days (D3, D4, D10, and D12) followed by unpaired t-tests to
determine the source of strain effect and paired t-test to determine
the source of strain × time interaction (Bonferroni-corrected). As
an additional measure of MA-CPP in AIL mice, we calculated the
difference in time spent on the MA-paired side between D1 and
D8 (D8–D1) and examined its correlation among variables as well
as estimated its heritability.
HERITABILITY ESTIMATES
We estimated the narrow-sense heritability (h2), or the proportion
of phenotypic variance explained by additive variance, using two
methods. First, we used midparent-offspring linear regression of
the F45 and F46 generations of AIL mice whereby h2 equals the
slope of the regression line of the offspring averages of the 10
families regressed onto the midparent averages; the standard error
of the estimate (SE) represents the standard error of the regression
coefﬁcient. Second, we used a mixed model that accounted for
genetic relatedness among individuals. Here, we used the complete
AIL pedigree (F1–F47) to calculate the kinship coefﬁcients and
partitioned the variance into genetic andnon-genetic components,
and then estimated the heritability using the maximum likelihood
estimates of the variance components (Abney et al., 2000). The
standard error of the heritability estimate was calculated using
the jackknife resampling method (Shao and Wu, 1989) from 50
different subsets of the original data with ten observations being
deleted.
RESULTS
MA-CPP IN LG/J AND SM/J STRAINS
A schematic of the MA-CPP protocol is shown in Figure 1.
Following the assessment of initial preference on D1, MA-CPP
was assessed twice; once on D8 and again on D15. Figure 2A illus-
tratesMA-CPP in LG/J (N = 31) and SM/J strains (N = 31).When
treating D1, D8, and D15 as repeated measures, there was a main
effect of day (F2,120 = 22.4; p < 0.05) but the strain × day inter-
action was not statistically signiﬁcant (F2,120 = 2.83; p = 0.06).
Therefore, the data were collapsed across strain and we observed
a signiﬁcant increase in time spent on the drug-paired side
on D8 compared to D1 (t61 = 5.77; p < 0.017, Bonferroni-
corrected; Figure 2A) and on D15 relative to D1 (t61 = 5.25;
p < 0.017). There was no further increase in preference from
D8 to D15 (t61 < 1), indicating maximal MA-CPP on D8
(Figure 2A).
LOCOMOTOR ACTIVITY IN LG/J AND SM/J MICE
In examining locomotor activity during the days of preference
assessment (D1, D8, and D15), there was no effect of strain
(F1,60 < 1), an effect of day (F2,120 = 12.9; p < 0.0001), and
no strain × day interaction (F2,120 < 1). The effect of day was
explained by mice showing a signiﬁcant decrease in locomotor
activity on D8 and D15 relative to D1 (t61 = 3.47, 4.43; p< 0.017;
Bonferroni-corrected; Figure 2B).
Figure 2C illustrates locomotor activity during MA training
days (D2, D4, D9, and D11) in LG/J and SM/J mice. Repeated
measures ANOVA of the four MA training days revealed a main
effect of strain (F1,60 = 68.55; p < 0.05), day (F3,180 = 17.61;
p< 0.05) and a strain× day interaction (F3,180 = 12.00; p< 0.05).
The effect of strain was explained by LG/J mice showing signiﬁ-
cantly less activity than SM/J mice on all 4 days (t60 = 9.09, 7.88,
6.84, 7.21; p < 0.013, Bonferroni-corrected). The strain × time
interaction was explained by LG/J showing a sensitized response
to MA from D2 to D4 and a further sensitized response between
D4 and D9 (t30 = 5.71, 4.44; p < 0.013). In contrast, SM/J mice
did not show any signiﬁcant increase in MA activity (MA-ACT)
relative to D2 (p > 0.013; Figure 2C).
Figure 2D illustrates locomotor activity during SAL training
days (D3, D5, D10, and D12). There was a signiﬁcant main effect
of strain (F1,60 = 21.58; p< 0.05) and a strain × time interaction
(F3,180 = 4.21; p< 0.05). The effect of strainwas explained by LG/J
showing signiﬁcantly less activity than SM/J mice on all 4 days
(t60 = 4.80, 4.16, 2.93, 3.18, p < 0.013; Bonferroni-corrected).
The interaction was explained by SM/J mice showing signiﬁcant
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FIGURE 2 | MA-CPP and MA-ACT in LG/J, SM/J, and AIL mice. (A,E)Time
spent on the MA-paired side (s) on D1 and then on D8 and D15 following
alternating MA and SAL trials. LG/J mice (N = 31) are represented by white
bars, SM/J mice (N = 31) are represented by the black bars, and AIL mice
(N = 105) are represented by gray bars. (B,F) Locomotor activity (total
distance traveled in cm; summed over 30 min) in LG/J (white circles), SM/J
(black circles), and AIL mice (gray circles; N = 105) during days of preference
assessment. (C,G) MA-induced locomotor activity during MA training trials
(D2, D4, D9, and D11) in LG/J, SM/J, and AIL mice. (D,H) Locomotor activity
during SAL training trials (D3, D5, D10, and D12) in LG/J, SM/J, and AIL mice.
*Signiﬁcantly different from D1 (A,B,E), D2 (C,G), or D3 (D,H). #Signiﬁcantly
different from SM/J (C,D). %Signiﬁcantly different from D4 (B) or D5 (C). All
signiﬁcant results were Bonferroni-corrected for multiple comparisons across
days (see Results).
habituation from D3 to D5 and from D5 to D10 (t30 = 3.42, 3.35;
p< 0.0083; Bonferroni-corrected). In contrast, LG/J mice did not
show any signiﬁcant decrease in activity following D3 (p> 0.0083;
Figure 2D).
MA-CPP AND LOCOMOTOR ACTIVITY IN AIL MICE
In examining MA-CPP in AIL mice (N = 105), paired t-test indi-
cated a signiﬁcant increase in preference for the MA-paired side
on D8 and D15 relative to D1 (t104 = 5.89, 5.74; p < 0.017;
Bonferroni-corrected), with no difference between D8 and D15
(t104 < 1; Figure 2E). Because of this last observation, we
focused our correlations and heritability calculations on variables
measured from D1 to D8 (see below).
In examining locomotor activity during the days of preference
assessment (D1, D8, and D15), there was no signiﬁcant change in
activity on D8 or D15 relative to D1 (t104 = 1.3, 1.59; p > 0.017;
Bonferroni-corrected; Figure 2F).
There was a small but signiﬁcant increase inMA-induced loco-
motor activity in AIL mice on D9 relative to D2 (t104 = 2.83;
p < 0.0083; Bonferroni-corrected; Figure 2G), which was the
only indication of locomotor sensitization. For SAL treatment
days, there was a signiﬁcant decrease in locomotor activity on
D5, D10, and D12 relative to D3 (t104 = 3.88, 3.78, 4.22;
p < 0.0083), indicating a persistent locomotor habituation
(Figure 2H).
SAL CONTROL EXPERIMENT IN AIL MICE
We performed a control experiment in which AIL mice received
SAL on both sides; the purpose of this study was to conﬁrm that
we would not see any CPP under these conditions. As expected,
there was no signiﬁcant change in preference for either side on D8
or D15 relative to D1 (t31 < 1; Figure 3A). Similarly, there was
no change in activity following SAL treatment on D3, D4, D5, D9,
D10, or D11 relative to D2 (t31 < 1; Figure 3B).
CORRELATION OF MA-CPP WITH D1 PREFERENCE AND LOCOMOTOR
PHENOTYPES IN AIL MICE
Because AIL mice segregate alleles from both LG/J and SM/J
strains, a correlation between two phenotypes implies that the
two traits may be genetically correlated – that is, shared alleles
contribute to both traits. Alternatively, a common environmental
factor could drive such a correlation. We wanted to determine if
MA-CPP was correlated with locomotor activity during training
or preference assessment. Because AIL mice showed maximum
MA-CPP on D8 (Figure 2E), we focused on phenotypes that were
measured from D1 to D8 (Table 1).
Importantly, MA-CPP as measured by the time spent on the
drug-paired side on D8 (D8 CPP) showed virtually zero cor-
relation with time spent on the drug-paired side on D1 (D1
preference; r = 0.05; p > 0.05; Table 1), indicating that the
ﬁnal preference for the drug-paired side was not dependent on
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FIGURE 3 | Preference and locomotor activity in a SAL control
experiment in AIL mice. (A)Time spent on the drug (left)-paired side on
D1 and on D8 and D15 following training with SAL administration in both
sides of the CPP apparatus in AIL mice (N = 32). (B) Locomotor activity
(centimeter) during the training trials where mice received SAL each day
(D2–D5; D9–D12).
Table 1 | Correlation of MA-CPP with D1 preference and locomotor
phenotypes in AIL mice.
Phenotype D8 CPP (s) D8-D1 CPP (s)
D1 preference (s) 0.05 −0.69*
D8 CPP (s) 1 0.69*
D8-D1 CPP (s) 0.69* 1
D1 ACT (cm) 0.13 0.03
D8 ACT (cm) 0.07 0.05
MA-ACT (cm) 0.05 −0.09
SAL-ACT(cm) 0.03 0.03
N = 105 (10 dams, 10 sires, 85 offspring). The variables include time spent
on the drug-paired side on D1 (D1 preference) and D8 (D8 CPP), difference
in time spent on the drug-paired side (D8–D1 CPP), locomotor activity during
preference assessment on D1 and D8 (D1 ACT and D8 ACT), and the average
locomotor activity duringMA trials (D2, D4; MA-ACT) and SAL training trials (D3,
D5; SAL-ACT). *p < 0.05 for Pearson’s correlation coefﬁcient.
an initially low or high preference for it. MA-induced locomo-
tor activity on D2 and D4 and SAL-induced locomotor activity
on D3 and D5 were both highly correlated (r = 0.77, 0.71;
p < 0.05; data not shown); therefore, we averaged across D2
and D4 for MA-ACT and across D3 and D5 for SAL activity
(SAL-ACT) in comparing their relationship with the preference
variables.
WhileD8CPPandD8-D1CPPwerehighly correlated (r = 0.69;
p < 0.05), neither of these MA-CPP measures correlated with
any measures of locomotor activity, including D1 ACT, D8 ACT,
MA-ACT (Table 1; Figures 4A,B), or SAL-ACT (r = −0.09 to
0.13; p > 0.05; Table 1), indicating that MA-CPP is not inﬂu-
enced by test session activity and implicating that the alleles
regulating the rewarding properties of MA are largely separate
from those regulating MA-ACT. Last, as expected based on our
previous observations with open ﬁeld activity in AIL mice, MA-
ACT and SAL-ACT were highly correlated (r = 0.57; p < 0.05;
Figure 4C).
HERITABILITY OF MA-CPP AND LOCOMOTOR PHENOTYPES IN AIL MICE
For the measures involving prior or present MA treatment (D8
CPP, D8-D1 CPP, MA-ACT), the heritability estimates were gen-
erally much lower than for locomotor activity following SAL
treatment (D1ACT,D8ACT,SAL-ACT). Speciﬁcally, the heritabil-
ity of D8CPP ranged from 0 to 0.21, the heritability of D8-D1CPP
ranged from 0 to 0.12, the heritability of MA-ACT ranged from 0
to 0.1, and the heritability estimates for drug-free locomotor activ-
ity following SAL treatment ranged from 0.33 to 0.68 (Table 2).
Interestingly, therewas a large strain difference inMA-ACT in LG/J
and SM/J mice (Figure 2C); thus, the low heritability of MA-ACT
cannot be explained by a lack of polymorphisms that contribute
to the trait. Conversely, there was no parental strain difference in
drug-free test session activity on D1 and D8 (Figure 2B), yet the
heritability of these two phenotypes was reliably moderate or high
(Table 2).
DISCUSSION
LG/J, SM/J, and AIL mice all exhibited MA-CPP and there was
no statistically signiﬁcant difference inMA-CPP between the LG/J
and SM/J parental inbred strains (Figure 2A) – a strain difference
would have suggested a genetic basis. However, the lack of strain
difference may be explained by several factors other than a lack of
genetic contribution. First, even though our sample size was large
(N = 31 per strain), we may have been underpowered to detect a
strain difference. In support, LG/J mice trended toward a greater
increase in MA-CPP on D15 relative to D1 (Figure 2A) and this
difference was signiﬁcant when considering just theD1 versus D15
comparison (data not shown). Previous studies demonstrated that
genetic variation contributes to motivational properties of MA in
mice as indicated by a correlated response to selection forMA oral
consumption and MA-CPP (Wheeler et al., 2009; Scibelli et al.,
2011; Shabani et al., 2011, 2012). However, LG/J and SM/J harbor
different alleles than the founder strains of these studies (C57BL/6J
and DBA/2J) and thus, the most relevant alleles for MA-CPP may
be present in other inbred strains. It should also be noted that a
phenotypic difference between strains is not necessary for a trait
to be heritable (e.g., D1 ACT and D8 ACT; Figure 2B; Table 2),
which may in part be explained by transgressive segregation
(Rieseberg et al., 1999).
AIL mice segregating LG/J and SM/J alleles showed a signiﬁ-
cant MA-CPP that was maximal after 1 week of training on D8
(Figure 2E). Thus, we have established a short-term CPP proto-
col that could be useful in forward genetic studies of MA reward.
Because AIL mice did not show any further increase in preference
on D15, we focused on the correlation between variables mea-
sured from D1 to D8. Importantly, MA-CPP did not correlate
with any measure of locomotor activity (Table 1), indicating that
MA reward is not confounded by test session activity and provid-
ing support that it is genetically separable from MA-ACT in this
population. This is important because it suggests that the genetic
architecture of MA-CPP will be, at least in part, distinct from
MA-ACT (Cheng et al., 2010).
We were drastically underpowered to accurately estimate her-
itability in this study as indicated by our large standard errors
of the estimate (SE; Table 2). Assuming equal offspring per
family (N = 2) and random mating, a minimum of 100
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FIGURE 4 | No correlation of MA-CPP with MA-ACT in AIL mice. (A,B)
Scatterplot of the average amount of MA-induced locomotor activity on D2
and D4 of training (MA-ACT) versus the time spent on the drug-paired side on
D8 (A; D8 MA-CPP) or versus the difference in time spent on the MA-paired
side between D1 and D8 (B; D8-D1 MA-CPP) in AIL mice (N = 105). (C)
Scatterplot of MA-ACT versus the average amount of SAL-induced locomotor
activity during D3 and D5 of training (SAL-ACT) in AIL mice. r, Pearson’s
correlation coefﬁcient. *p < 0.05.
Table 2 | Heritability estimates of preference and locomotor
phenotypes in AIL mice.
Phenotype h2 (SE): midparent-offspring h2 (SE): maximum
regression likelihood
D1 preference (s) 0.17 (0.14) 0.00 (0.00)
D8 CPP (s) 0.21 (0.10) 0.00 (0.33)
D8-D1 CPP (s) 0.12 (0.10) 0.00 (0.00)
D1 ACT (cm) 0.34 (0.23) 0.45 (0.33)
D8 ACT (cm) 0.52 (0.21) 0.68 (0.17)
MA-ACT (cm) 0.1 (0.13) 0.00 (0.31)
SAL-ACT (cm) 0.33 (0.19) 0.62 (0.29)
N = 105 (10 dams, 10 sires, 85 offspring). The ﬁrst column lists the various
preference and locomotor measures (ACT). The second column represents the
heritability estimates (h2) using midparent-offspring regression of the F45 and F46
generations of AIL mice. The third column represents the heritability estimates
obtained when accounting for genetic relatedness using maximum likelihood
estimation. SE, standard error of the estimate.
midparent-offspring observations were estimated to be required
to demonstrate that a trait with a heritability of 0.2 is signiﬁcantly
different from 0 (Klein et al., 1973). Under the same conditions
and with an alpha level of 0.05, 60% power is achieved – 400
families would be required to achieve greater than 95% power
(Klein, 1974). With this in mind, our heritability estimates for
both MA-CPP andMA-ACT using 10 midparent-offspring obser-
vations were low (h2 = 0–0.21, 0–0.1, respectively) and variable
(SE = 0–0.33, 0.13–0.31, respectively; Table 2). Despite the low
heritability estimate for MA-ACT, we previously mapped several
QTLs for this phenotype in the F34 generation of AILmice (Cheng
et al., 2010). In contrast to MA-ACT, drug-free locomotor activity
showed little or no signiﬁcant difference between parental strains
(Figures 2B,D); however, it was the most heritable set of traits
across both methods of estimation, ranging from 0.33 to 0.68.
This observation is consistent with prior reports (Crabbe et al.,
1999; Mhyre et al., 2005; Miller et al., 2010; Philip et al., 2010). To
summarize, we cannot conclude based on the present set of data
whether MA-CPP is sufﬁciently heritable for QTL mapping.
The heritability of cocaine-CPP was recently estimated to be
0.11 (Philip et al., 2010), which is within our range for MA-CPP
(0–0.21; Table 2). In general, heritability studies are not compa-
rable across different populations and environmental conditions
(Visscher et al., 2008). Philip et al. (2010) used a panel of BXD
recombinant inbred strains (derived from C57BL/6J and DBA/2J
strains) whereas our study examined alleles derived from the LG/J
and SM/J strains. Furthermore, different drugs were used (cocaine
versus MA) with different time courses of action and the doses
may not have been comparable in potency (10 mg/kg cocaine ver-
sus 2 mg/kg MA). The CPP procedures were also very different
between Philip et al. (2010) versus the present study including (1)
the length of training and testing trials (20 min versus 30 min),
(2) the number of trials per day (SAL and cocaine trials on the
same day versus MA and SAL trials on separate days), (3) the
time separating drug and SAL exposures (cocaine trials immedi-
ately following SAL trials on the same day versus 24 h separating
MA and SAL trials), (4) the total number of drug and SAL tri-
als (six versus eight or 16 trials), (5) the number of chambers
within the CPP apparatus (three chambers versus two chambers),
and (6) the size of the training chambers (18 cm × 14 cm ver-
sus 37.5 cm × 18.75 cm). Importantly, we observed a relatively
large increase in time spent on the drug-paired side (100–250 s;
Figures 2A,E) compared to Philip et al. (2010; 25–30 s maximal
preference).
Support for MA-CPP as a heritable trait comes from studies
where C57BL/6J × DBA/2J F2 mice were selected for high and
low oral liquid consumption of MA. The amount of MA con-
sumed is thought to measure the motivational properties of MA;
this assumption was supported by the high and low lines differing
both in MA-CPP (greater in the high line) and MA-conditioned
place aversion (CPA; greater in the low line; Wheeler et al., 2009;
Shabani et al., 2011). Because MA oral consumption was heritable
(h2 = 0.34–0.35; Wheeler et al., 2009; Shabani et al., 2011) and
because MA-CPP showed a correlated response to selection, this
suggests thatMA-CPP is also heritable. TheCPP assay is both com-
plementary to anddistinct from theoral consumptionparadigm in
that it requires mice both to discriminate contexts and to associate
a particular context with the motivational effects of the drug.
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Drug-associated cues induce powerful neurobiological and psy-
chological states in the brain that motivate drug seeking behavior
in addicts (Volkow et al., 2011). Thus, identifying the genetic basis
of MA-CPPmay reveal genes important for both the motivational
properties as well as those important for associative learning and
cue-associated craving.
Because we are interested both in identifying QTLs for MA-
CPP as well as further narrowing the QTLs already identiﬁed for
MA-ACT (Cheng et al., 2010), the use of the MA-CPP protocol
should permit the latter ancillary goal in the more highly recom-
binant AIL generations. In support, B6 congenic mice capturing
a major QTL on chromosome 11 for MA-ACT in the open ﬁeld
(Bryant et al., 2009) captured this same QTL for MA-ACT in the
drug-paired chamber of the CPP apparatus (Bryant et al., 2012a),
supporting the presumption that the smaller sized CPP cham-
ber may be used to detect the same QTLs for MA-ACT as the
open ﬁeld.
An important limitation of this study was that we only exam-
ined a single systemic dose of MA (2 mg/kg) which was based
solely on our historical use of this dose in previous QTL stud-
ies involving MA-induced locomotor activity. Indeed, lower doses
(e.g., 0.5 mg/kg) produced a greater MA-CPP in mice (Shabani
et al., 2011). Thus, our ﬁndings may be speciﬁc to this dose of
MA. There are also several other parameters that could poten-
tially change the correlation among CPP and locomotor variables
and their heritability estimates (see above). Thus, we have not
attempted to completely explore the large and complex parameter
space for CPP in the parental strains or in AIL mice.
We have outlined a short-term protocol in AIL mice that may
be useful for identifying the genetic basis of the rewarding prop-
erties of MA and possibly other drugs of abuse. Our estimates of
heritability for MA-CPP and indeed, for MA-ACT were low and
underpowered. Becausewe previouslymappedQTLs forMA-ACT
in AIL mice, this suggests that we have not accurately estimated
the true heritability and thus, it is possible that we will also have
success in mapping QTLs for MA-CPP under these conditions.
We believe that the minimal extra labor required warrants its use
with the hope that multiple MA traits relevant to drug abuse will
be mapped. The use of AIL could greatly accelerate the identiﬁ-
cation of the responsible genes contributing to the conditioned
rewarding properties of MA and nicely complements efforts that
are currently underway to identify the genetic basis of MA oral
consumption (Wheeler et al., 2009). In addition, genes important
for the conditioned rewarding properties of drugs of abuse could
have important pleiotropic roles inmultiple neuropsychiatric con-
ditions affected by the mesolimbic dopaminergic reward pathway
including the non-drug addictions, the emotional-affective com-
ponent of pain and analgesia, Parkinson’s disease, anxiety, and
depression.
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